Chronic intravascular coagulation in liver cirrhosis predicts a high hemorrhagic risk. 2021

M F Ruberto, and M S Piras, and O Sorbello, and A Civolani, and P Usai, and D Fanni, and G Orrù, and G Faa, and F Marongiu, and D Barcellona
Hemostasis and Thrombosis Unit, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy. rubertofilomena@tiscali.it.

OBJECTIVE In liver cirrhosis, a complex coagulopathy does exist. The aim was to investigate whether a possible chronic consumption coagulopathy is the underlying phenomenon of the disease. METHODS We measured endogenous thrombin generation with and without thrombomodulin (ETP ratio) along with D-Dimer in a group of consecutive 282 cirrhotic patients. Fibrinogen, Platelet count and the Hemorrhagic score were previously computed in the same patients. The ETP ratio represents the resistance to the anticoagulant activity of TM and should be considered as an index of a procoagulant imbalance. RESULTS ETP ratio and D-Dimer showed higher values in the cirrhotic patients when compared to controls thus showing a hypercoagulable state. When the patients were divided based on the Hemorrhagic score >7, we found that Fibrinogen, ETP ratio, D-Dimer and the platelet count were significantly different between the two groups. Again, when we considered ETP ratio >0.88, the median value of the cirrhotic patients, all parameters, were statistically different between the two groups. D-Dimer were higher while fibrinogen and platelet count were statistically lower in cirrhotic patients with higher ETP ratio values. Even when the same patients were divided based on their platelet count (</> 100 x 109/L) the results showed a similar behavior. ROC curves showed significant AUCs when the hemorrhagic score was challenged against Fibrinogen, D-Dimer, Platelet count and ETP ratio. CONCLUSIONS In liver cirrhosis hypercoagulable state is associated with an increase in D-Dimer levels along with a decrease in fibrinogen and platelet count thus indicating a low-grade intravascular coagulation which predicts a high hemorrhagic risk.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010976 Platelet Count The number of PLATELETS per unit volume in a sample of venous BLOOD. Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D005260 Female Females
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M F Ruberto, and M S Piras, and O Sorbello, and A Civolani, and P Usai, and D Fanni, and G Orrù, and G Faa, and F Marongiu, and D Barcellona
December 2021, European review for medical and pharmacological sciences,
M F Ruberto, and M S Piras, and O Sorbello, and A Civolani, and P Usai, and D Fanni, and G Orrù, and G Faa, and F Marongiu, and D Barcellona
July 1992, Journal of hepatology,
M F Ruberto, and M S Piras, and O Sorbello, and A Civolani, and P Usai, and D Fanni, and G Orrù, and G Faa, and F Marongiu, and D Barcellona
August 1979, La Clinica terapeutica,
M F Ruberto, and M S Piras, and O Sorbello, and A Civolani, and P Usai, and D Fanni, and G Orrù, and G Faa, and F Marongiu, and D Barcellona
June 1971, Sovetskaia meditsina,
M F Ruberto, and M S Piras, and O Sorbello, and A Civolani, and P Usai, and D Fanni, and G Orrù, and G Faa, and F Marongiu, and D Barcellona
June 1987, Revista espanola de las enfermedades del aparato digestivo,
M F Ruberto, and M S Piras, and O Sorbello, and A Civolani, and P Usai, and D Fanni, and G Orrù, and G Faa, and F Marongiu, and D Barcellona
March 1988, Minerva medica,
M F Ruberto, and M S Piras, and O Sorbello, and A Civolani, and P Usai, and D Fanni, and G Orrù, and G Faa, and F Marongiu, and D Barcellona
October 1999, The American journal of gastroenterology,
M F Ruberto, and M S Piras, and O Sorbello, and A Civolani, and P Usai, and D Fanni, and G Orrù, and G Faa, and F Marongiu, and D Barcellona
January 1972, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
M F Ruberto, and M S Piras, and O Sorbello, and A Civolani, and P Usai, and D Fanni, and G Orrù, and G Faa, and F Marongiu, and D Barcellona
July 1989, Hepatology (Baltimore, Md.),
M F Ruberto, and M S Piras, and O Sorbello, and A Civolani, and P Usai, and D Fanni, and G Orrù, and G Faa, and F Marongiu, and D Barcellona
January 1985, Thrombosis research,
Copied contents to your clipboard!